VERA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 21.70%

Insider Buying (Last 12 Months): $4,999,990.00

Insider Selling (Last 12 Months): $41,594,649.34

Vera Therapeutics Insider Trading History Chart

Vera Therapeutics Share Price & Price History

^$41.64

▲ +1.31 (3.25%)

As of 09/19/2024 01:46 PM ET

Days: 30 | 90 | 365

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

From Paradigm Press | Ad

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

Vera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2024	Marshall Fordyce	CEO	Sell	15,625	$37.50	$585,937.50	307,972
8/21/2024	Marshall Fordyce	CEO	Sell	14,471	$39.76	$575,366.96	322,667
4/10/2024	Joseph R Young	SVP	Sell	5,714	$40.00	$228,560.00	53,171
4/3/2024	Sean Grant	CFO	Sell	99,828	$39.61	$3,954,187.08	66,337
3/25/2024	Maha Katabi	Director	Sell	340,000	$40.50	$13,770,000.00	2,793,987
3/21/2024	Maha Katabi	Director	Sell	81,009	$44.20	$3,580,597.80	3,547,437
1/30/2024	Maha Katabi	Director	Buy	161,290	$31.00	$4,999,990.00	3,628,446
1/10/2024	Commodore Capital Lp	Major Shareholder	Sell	1,050,000	$18.00	$18,900,000.00	4,400,000
8/21/2023	Celia Lin	Insider	Sell	1,490	$16.65	$24,808.50	11,010
8/21/2023	Marshall Fordyce	CEO	Sell	5,210	$16.66	$86,798.60	243,361
6/23/2023	Sean Grant	CFO	Buy	5,000	$16.60	$83,000.00	5,992
6/20/2023	Commodore Capital Lp	Major Shareholder	Buy	448,217	$15.17	$6,799,451.89	5,450,000
3/30/2023	Beth C Seidenberg	Director	Buy	2,300	$7.24	$16,652.00	1,949,295
3/27/2023	Beth C Seidenberg	Director	Buy	1,633	$7.24	$11,822.92	1,923,087
3/24/2023	Beth C Seidenberg	Director	Buy	1,833	$7.24	$13,270.92	1,921,454
3/20/2023	Beth C Seidenberg	Director	Buy	15,252	$7.21	$109,966.92	1,919,621
3/17/2023	Beth C Seidenberg	Director	Buy	74,045	$7.12	$527,200.40	1,904,369
3/15/2023	Beth C Seidenberg	Director	Buy	32,844	$7.12	$233,849.28	1,770,227
3/10/2023	Beth C Seidenberg	Director	Buy	48,003	$7.16	$343,701.48	1,737,383
3/3/2023	Beth C Seidenberg	Director	Buy	1,000	$7.25	$7,250.00	1,689,380
3/1/2023	Beth C Seidenberg	Director	Buy	100	$7.25	$725.00	1,665,002
2/23/2023	Beth C Seidenberg	Director	Buy	200	$7.24	$1,448.00	1,664,902
2/13/2023	Beth C Seidenberg	Director	Buy	10,072	$7.20	$72,518.40	1,664,702
2/8/2023	Beth C Seidenberg	Director	Buy	45,357	$7.22	$327,477.54	1,654,230
2/6/2023	Patrick G Enright	Director	Buy	1,714,285	$7.00	$11,999,995.00	1,714,285
2/6/2023	Sofinnova Venture Partners X,	Major Shareholder	Buy	285,714	$7.00	$1,999,998.00	3,467,156
2/3/2023	Beth C Seidenberg	Director	Buy	46,163	$7.24	$334,220.12	1,389,315
12/16/2022	Joanne Curley	Insider	Sell	2,212	$19.49	$43,111.88	26,821
11/17/2022	Joanne Curley	Insider	Sell	3,289	$15.85	$52,130.65	27,315
10/18/2022	Joanne Curley	Insider	Sell	8,590	$19.41	$166,731.90	27,809
10/5/2022	Joanne Curley	Insider	Sell	988	$21.64	$21,380.32	27,809
10/4/2022	Marshall Fordyce	CEO	Sell	18,223	$21.19	$386,145.37	181,150
9/20/2022	Joanne Curley	Insider	Sell	15,666	$20.67	$323,816.22	28,797
9/12/2022	Marshall Fordyce	CEO	Sell	16,136	$20.64	$333,047.04	181,150
9/8/2022	Marshall Fordyce	CEO	Sell	15,106	$20.52	$309,975.12	181,150
8/22/2022	Joanne Curley	Insider	Sell	1,630	$18.87	$30,758.10	29,785
8/19/2022	Joanne Curley	Insider	Sell	6,909	$19.20	$132,652.80	29,785
8/17/2022	Carlyle Group Inc.	Major Shareholder	Sell	9,925	$20.25	$200,981.25	2,960,231
8/12/2022	Marshall Fordyce	CEO	Sell	20,528	$20.16	$413,844.48	137,400
8/3/2022	Joanne Curley	Insider	Sell	988	$16.81	$16,608.28	17,285
7/19/2022	Joanne Curley	Insider	Sell	11,444	$16.01	$183,218.44	18,273
7/14/2022	Joanne Curley	Insider	Sell	9,104	$15.14	$137,834.56	18,273
7/7/2022	Joanne Curley	Insider	Sell	9,666	$15.05	$145,473.30	21,023
6/22/2022	Joanne Curley	Insider	Sell	1,545	$15.01	$23,190.45	23,688
6/17/2022	Joanne Curley	Insider	Sell	5,887	$15.04	$88,540.48	23,994
6/15/2022	Sean Grant	CFO	Buy	5,000	$13.60	$68,000.00	2,816
2/10/2022	Patrick G Enright	Director	Buy	333,333	$15.00	$4,999,995.00
2/10/2022	Sofinnova Venture Partners X,	Major Shareholder	Buy	266,666	$15.00	$3,999,990.00

Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute

From Monetary Gold | Ad

Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.

This means you must act NOW before it's too late.

SEC Filings (Institutional Ownership Changes) for Vera Therapeutics (NASDAQ:VERA)

99.21% of Vera Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/16/2024	Point72 Asia Singapore Pte. Ltd.	4,493	$0.16M	0.0%	N/A	0.008%
8/19/2024	Point72 Asset Management L.P.	119,000	$4.31M	0.0%	-89.9%	0.218%
8/16/2024	Quarry LP	6,500	$0.24M	0.1%	N/A	0.012%
8/16/2024	Algert Global LLC	17,254	$0.62M	0.0%	+38.9%	0.032%
8/16/2024	Driehaus Capital Management LLC	255,133	$9.23M	0.1%	-0.8%	0.466%
8/15/2024	The Manufacturers Life Insurance Company	102,037	$3.69M	0.0%	+28.0%	0.187%
8/15/2024	Deerfield Management Company L.P. Series C	6,191	$0.22M	0.0%	-39.4%	0.011%
8/15/2024	Decheng Capital LLC	69,767	$2.52M	0.8%	N/A	0.128%
8/15/2024	AQR Capital Management LLC	9,682	$0.35M	0.0%	-52.6%	0.018%
8/15/2024	AXA S.A.	246,201	$8.91M	0.0%	-9.5%	0.450%
8/15/2024	Affinity Asset Advisors LLC	375,000	$13.57M	1.6%	-20.2%	0.686%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	4,493	$0.16M	0.0%	N/A	0.008%
8/14/2024	Squarepoint Ops LLC	148,011	$5.36M	0.0%	+316.5%	0.271%
8/14/2024	Cubist Systematic Strategies LLC	53,940	$1.95M	0.0%	+98.8%	0.099%
8/14/2024	First Light Asset Management LLC	1,005,723	$36.39M	3.2%	+130.6%	1.839%
8/14/2024	Point72 DIFC Ltd	40,413	$1.46M	0.1%	+1,932.8%	0.074%
8/14/2024	Marshall Wace LLP	524,578	$18.98M	0.0%	+9.2%	0.959%
8/14/2024	Samlyn Capital LLC	1,231,911	$44.57M	0.7%	+90.8%	2.252%
8/14/2024	Logos Global Management LP	950,000	$34.37M	2.8%	+65.2%	1.733%
8/14/2024	Integral Health Asset Management LLC	500,000	$18.09M	1.7%	+38.9%	0.914%
8/14/2024	Adams Street Partners LLC	13,114	$0.47M	0.2%	N/A	0.024%
8/14/2024	Magnetar Financial LLC	18,021	$0.65M	0.0%	N/A	0.033%
8/14/2024	Avoro Capital Advisors LLC	4,309,590	$155.92M	2.1%	-18.1%	7.878%
8/14/2024	HighVista Strategies LLC	9,162	$0.33M	0.1%	N/A	0.017%
8/14/2024	ProShare Advisors LLC	8,749	$0.32M	0.0%	-19.6%	0.016%
8/14/2024	Profund Advisors LLC	22,396	$0.81M	0.0%	-18.1%	0.041%
8/13/2024	Ensign Peak Advisors Inc	11,750	$0.43M	0.0%	+13.5%	0.021%
8/13/2024	Sei Investments Co.	10,824	$0.39M	0.0%	-2.6%	0.020%
8/13/2024	Public Employees Retirement Association of Colorado	3,718	$0.14M	0.0%	N/A	0.007%
8/12/2024	Seven Eight Capital LP	9,243	$0.33M	0.0%	-85.1%	0.017%
8/12/2024	E Fund Management Co. Ltd.	7,395	$0.27M	0.0%	-10.5%	0.014%
8/9/2024	Renaissance Technologies LLC	147,800	$5.35M	0.0%	+28.5%	0.270%
8/8/2024	Federated Hermes Inc.	290,000	$10.49M	0.0%	N/A	0.530%
8/8/2024	First Turn Management LLC	212,944	$7.70M	1.3%	+80.1%	0.389%
8/8/2024	Nicholas Investment Partners LP	59,129	$2.14M	0.2%	N/A	0.108%
8/8/2024	American Century Companies Inc.	387,380	$14.02M	0.0%	N/A	0.708%
8/6/2024	Candriam S.C.A.	293,760	$10.63M	0.1%	+172.0%	0.537%
8/5/2024	Arizona State Retirement System	9,907	$0.36M	0.0%	+14.4%	0.018%
8/5/2024	Victory Capital Management Inc.	33,707	$1.22M	0.0%	+202.4%	0.062%
8/3/2024	TD Asset Management Inc	154,338	$5.58M	0.0%	+18.4%	0.282%
8/1/2024	Rhumbline Advisers	54,859	$1.99M	0.0%	-5.0%	0.100%
7/29/2024	Principal Financial Group Inc.	7,230	$0.26M	0.0%	-46.3%	0.013%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	7,527	$0.27M	0.0%	+30.0%	0.014%
7/26/2024	Legato Capital Management LLC	7,551	$0.27M	0.0%	N/A	0.014%
7/26/2024	Bank of New York Mellon Corp	165,322	$5.98M	0.0%	+6.3%	0.302%
7/26/2024	EFG Asset Management North America Corp.	31,444	$1.14M	0.2%	+204.0%	0.057%
7/19/2024	William Marsh Rice University	16,397	$0.59M	0.7%	N/A	0.030%
7/12/2024	SG Americas Securities LLC	4,301	$0.16M	0.0%	-64.0%	0.008%
5/30/2024	Cambridge Trust Co.	48,107	$2.07M	0.1%	+386.6%	0.088%
5/24/2024	Cetera Advisors LLC	5,460	$0.24M	0.0%	N/A	0.010%
5/20/2024	Virtu Financial LLC	8,704	$0.38M	0.0%	N/A	0.016%
5/17/2024	Artal Group S.A.	506,019	$21.82M	0.6%	N/A	0.929%
5/16/2024	California State Teachers Retirement System	32,359	$1.40M	0.0%	+18.7%	0.059%
5/16/2024	Jacobs Levy Equity Management Inc.	20,196	$0.87M	0.0%	-1.3%	0.037%
5/16/2024	Kynam Capital Management LP	1,526,787	$65.84M	6.9%	-58.2%	2.804%
5/16/2024	Bayesian Capital Management LP	13,422	$0.58M	0.1%	N/A	0.025%
5/15/2024	First Light Asset Management LLC	436,133	$18.81M	1.4%	N/A	0.801%
5/15/2024	Price T Rowe Associates Inc. MD	2,393,029	$103.19M	0.0%	N/A	4.395%
5/15/2024	Avoro Capital Advisors LLC	5,265,000	$227.03M	2.7%	N/A	9.669%
5/15/2024	Affinity Asset Advisors LLC	470,000	$20.27M	2.5%	N/A	0.863%
5/14/2024	Platinum Investment Management Ltd.	153,932	$6.64M	0.3%	-23.2%	0.283%
5/14/2024	American International Group Inc.	19,764	$0.85M	0.0%	+17.6%	0.036%
5/13/2024	Seven Eight Capital LP	61,968	$2.67M	0.3%	N/A	0.114%
5/13/2024	Ameritas Investment Partners Inc.	4,000	$0.17M	0.0%	+20.8%	0.007%
5/10/2024	Vanguard Group Inc.	2,148,714	$92.65M	0.0%	+31.5%	3.946%
5/9/2024	Lord Abbett & CO. LLC	225,581	$9.73M	0.0%	N/A	0.414%
5/8/2024	ProShare Advisors LLC	10,885	$0.47M	0.0%	N/A	0.020%
5/8/2024	Russell Investments Group Ltd.	16,209	$0.70M	0.0%	+3,526.2%	0.030%
5/7/2024	Sei Investments Co.	11,109	$0.48M	0.0%	N/A	0.020%
5/7/2024	Swiss National Bank	62,200	$2.68M	0.0%	+27.7%	0.114%
5/7/2024	SG Americas Securities LLC	11,941	$0.52M	0.0%	+54.9%	0.022%
5/2/2024	Jennison Associates LLC	74,939	$3.23M	0.0%	N/A	0.138%
5/2/2024	FORA Capital LLC	16,058	$0.69M	0.1%	N/A	0.029%
5/1/2024	Capstone Investment Advisors LLC	5,756	$0.25M	0.0%	N/A	0.011%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	13,030	$0.56M	0.0%	-43.6%	0.024%
4/29/2024	China Universal Asset Management Co. Ltd.	10,117	$0.44M	0.1%	+96.7%	0.018%
2/14/2024	Kynam Capital Management LP	3,650,339	$56.14M	6.2%	+23.5%	6.953%
2/14/2024	Pale Fire Capital SE	16,389	$0.25M	0.0%	N/A	0.031%
2/14/2024	Sectoral Asset Management Inc.	124,151	$1.91M	0.8%	-65.2%	0.236%
2/14/2024	Schroder Investment Management Group	1,110,960	$17.09M	0.0%	N/A	2.116%
2/13/2024	Rafferty Asset Management LLC	170,758	$2.63M	0.0%	+25.2%	0.325%
2/12/2024	Crestline Management LP	60,069	$0.92M	0.1%	+32.4%	0.114%
2/6/2024	Amalgamated Bank	3,846	$59K	0.0%	-8.2%	0.009%
2/1/2024	New York State Common Retirement Fund	17,491	$0.27M	0.0%	+55.5%	0.039%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	23,116	$0.36M	0.0%	+12.3%	0.052%
1/24/2024	China Universal Asset Management Co. Ltd.	5,143	$79K	0.0%	N/A	0.012%
1/16/2024	Raymond James & Associates	27,199	$0.42M	0.0%	-4.7%	0.061%
1/12/2024	SG Americas Securities LLC	7,709	$0.12M	0.0%	N/A	0.017%
12/18/2023	Vanguard Group Inc.	1,574,390	$21.59M	0.0%	+9.3%	3.544%
12/6/2023	Citigroup Inc.	57,390	$0.79M	0.0%	+470.0%	0.129%
12/1/2023	Wellington Management Group LLP	84,506	$1.16M	0.0%	N/A	0.190%
11/15/2023	Sectoral Asset Management Inc.	357,139	$4.90M	1.0%	+1.6%	0.806%
11/15/2023	Kynam Capital Management LP	2,956,053	$40.53M	6.6%	-1.5%	6.670%
11/14/2023	Profund Advisors LLC	23,114	$0.32M	0.0%	N/A	0.052%
11/13/2023	FMR LLC	5,445,366	$74.66M	0.0%	-16.7%	12.286%
11/13/2023	Rafferty Asset Management LLC	136,377	$1.87M	0.0%	N/A	0.308%
11/9/2023	Citigroup Inc.	57,390	$0.79M	0.0%	+470.0%	0.129%
11/8/2023	Swiss National Bank	48,700	$0.67M	0.0%	N/A	0.110%
11/8/2023	Amalgamated Bank	4,189	$57K	0.0%	+26.0%	0.009%
11/7/2023	Barclays PLC	71,703	$0.98M	0.0%	+964.6%	0.162%

Data available starting January 2016

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Today's Range

Now: $41.64

$40.96

$42.80

50 Day Range

MA: $37.26

$34.09

$40.33

52 Week Range

Now: $41.64

$9.24

$50.78

Volume

344,081 shs

Average Volume

911,381 shs

Market Capitalization

$2.28 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Who are the company insiders with the largest holdings of Vera Therapeutics?: Vera Therapeutics' top insider shareholders include:
Commodore Capital Lp (Major Shareholder)
Maha Katabi (Director)
Sofinnova Venture Partners X, (Major Shareholder)
Beth C Seidenberg (Director)
Patrick G Enright (Director)
Marshall Fordyce (CEO)
Sean Grant (CFO)
Joseph R Young (SVP)
Joanne Curley (Insider)
Celia Lin (Insider)
Learn More about top insider investors at Vera Therapeutics.
Who are the major institutional investors of Vera Therapeutics?: Vera Therapeutics' top institutional shareholders include:
Avoro Capital Advisors LLC — 7.88%
Samlyn Capital LLC — 2.25%
First Light Asset Management LLC — 1.84%
Logos Global Management LP — 1.73%
Marshall Wace LLP — 0.96%
Integral Health Asset Management LLC — 0.91%
Learn More about top institutional investors of Vera Therapeutics stock.
Which major investors are selling Vera Therapeutics stock?: During the previous quarter, VERA stock was sold by these institutional investors:
Point72 Asset Management L.P.
Avoro Capital Advisors LLC
Affinity Asset Advisors LLC
Seven Eight Capital LP
AXA S.A.
AQR Capital Management LLC
SG Americas Securities LLC
Principal Financial Group Inc.
In the previous year, company insiders that have sold Vera Therapeutics company stock include:
Commodore Capital Lp (Major Shareholder)
Maha Katabi (Director)
Sofinnova Venture Partners X, (Major Shareholder)
Beth C Seidenberg (Director)
Patrick G Enright (Director)
Learn More investors selling Vera Therapeutics stock.
Which major investors are buying Vera Therapeutics stock?: During the previous quarter, VERA stock was purchased by institutional investors including:
Samlyn Capital LLC
First Light Asset Management LLC
American Century Companies Inc.
Logos Global Management LP
Federated Hermes Inc.
Candriam S.C.A.
Integral Health Asset Management LLC
Squarepoint Ops LLC
Within the previous year, these company insiders have bought Vera Therapeutics stock:
Commodore Capital Lp (Major Shareholder)
Maha Katabi (Director)
Sofinnova Venture Partners X, (Major Shareholder)
Beth C Seidenberg (Director)
Patrick G Enright (Director)
Marshall Fordyce (CEO)
Learn More investors buying Vera Therapeutics stock.